ES2013359A6 - Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados. - Google Patents

Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.

Info

Publication number
ES2013359A6
ES2013359A6 ES8803356A ES8803356A ES2013359A6 ES 2013359 A6 ES2013359 A6 ES 2013359A6 ES 8803356 A ES8803356 A ES 8803356A ES 8803356 A ES8803356 A ES 8803356A ES 2013359 A6 ES2013359 A6 ES 2013359A6
Authority
ES
Spain
Prior art keywords
polymerized
molecular weight
procedure
production
allergenis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803356A
Other languages
English (en)
Inventor
Lubertus Berrens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CORPORACION BIOLOG FARMACEUTIC
Original Assignee
CORPORACION BIOLOG FARMACEUTIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CORPORACION BIOLOG FARMACEUTIC filed Critical CORPORACION BIOLOG FARMACEUTIC
Priority to ES8803356A priority Critical patent/ES2013359A6/es
Priority to EP19890200116 priority patent/EP0367306A3/en
Priority to JP1103312A priority patent/JPH02138130A/ja
Publication of ES2013359A6 publication Critical patent/ES2013359A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA FABRICACION DE ALERGENOS INMUNOGENICOS POLIMERIZADOS. PROCEDIMIENTO PARA LA FABRICACION DE ALERGENOS INMUNOGENICOS POLIMERIZADOS Y CON ENLACES TRANSVERSALES (<CROSS-LINKED>) PARA EL TRATAMIENTO CLINICO DE ALERGIAS. LOS COMPONENTES ALERGENOS DE ELEVADO PESO MOLECULAR SON POLIMERIZADOS CON GLUTARDIALDEHIDO. LA REACCION SE DETIENE POR ADICION DE GLICINA U OTROS AMINOACIDOS O AMINAS PRIMARIAS. LOS PRODUCTOS DE REACCION CON PESO MOLECULAR INFERIOR A 100.000 DALTONS SE ELIMINAN POR FILTRACION MOLECULAR, DIALISIS O TAMIZADO. LOS COMPONENTES CON PESO MOLECULAR SUPERIOR A 100.000 DALTONS SE CONCENTRAN Y GUARDAN CONGELADOS EN SOLUCION O LIOFILIZACION EN ESTADO DOLISO.
ES8803356A 1988-11-04 1988-11-04 Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados. Expired - Lifetime ES2013359A6 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES8803356A ES2013359A6 (es) 1988-11-04 1988-11-04 Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
EP19890200116 EP0367306A3 (en) 1988-11-04 1989-01-19 Procedure for polymerized allergenis production
JP1103312A JPH02138130A (ja) 1988-11-04 1989-04-21 重合されたアレルゲンの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8803356A ES2013359A6 (es) 1988-11-04 1988-11-04 Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.

Publications (1)

Publication Number Publication Date
ES2013359A6 true ES2013359A6 (es) 1990-05-01

Family

ID=8258799

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803356A Expired - Lifetime ES2013359A6 (es) 1988-11-04 1988-11-04 Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.

Country Status (3)

Country Link
EP (1) EP0367306A3 (es)
JP (1) JPH02138130A (es)
ES (1) ES2013359A6 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328991A (en) * 1989-11-03 1994-07-12 Immulogic Pharmaceutical Corp. Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5091318A (en) * 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
ES2300100T3 (es) * 1991-10-16 2008-06-01 Merck Patent Gmbh Metodos para el diseño de peptidos de epitodo recombinado.
GB9508785D0 (en) * 1995-04-29 1995-06-21 Smithkline Beecham Plc Novel compositions
ES2108614B1 (es) * 1995-07-12 1998-07-16 Oncina Fco Javier Martin Vacunas polimerizadas.
HUP0004831A3 (en) 1997-10-30 2001-09-28 Leti Lab Tolerogenic fragments of natural allergens
ATE482721T1 (de) 2007-08-15 2010-10-15 Circassia Ltd Peptide zur desensibilisierung gegenüber allergenen
CN102821785B (zh) * 2010-02-12 2014-12-10 过敏症研究实验室有限公司 生产过敏原提取物的方法
GB201106802D0 (en) * 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition

Also Published As

Publication number Publication date
EP0367306A3 (en) 1990-09-19
EP0367306A2 (en) 1990-05-09
JPH02138130A (ja) 1990-05-28

Similar Documents

Publication Publication Date Title
ES2013359A6 (es) Procedimiento para la fabricacion de alergenos inmunogenicos polimerizados.
CA2141803A1 (en) Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
OA07291A (fr) Gilet orthopédique de soutien et de contention dans le traitement des traumatisés et des opérés de l&#39;épaule, de la ceinture scapulaire et du membre supérieur.
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
DK288586D0 (da) Glucosepolymer og fremgangsmaade til fremstilling heraf
NO892386L (no) Alginatgeler.
CA2006658A1 (en) An anticoagulant substance obtained from urine
NO305868B1 (no) Alginat-oligosakkarid, framgangsmÕte for framstilling av alginat-oligosakkarid i blodtrykksendende nµringsmiddel
IL91184A0 (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
DE69508890D1 (de) Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen
EP0345614A3 (en) Amblyommine as an agent for use in antithrombotic therapy
EP0401755A3 (en) Prosthesis for reducing and locking limb bone fractures
ATE261735T1 (de) Verwendung von wirkstoffen zur herstellung von arzeinmitteln zur behandlung der rheumatischen arthritis
GB8823804D0 (en) Proteinaceous composition
NO892758D0 (no) Fremgangsmaate for fremstilling av polymerisering av kromener og derved oppnaadde produkter.
EP0300741A3 (en) Human thymopoietin
JP3255643B2 (ja) エスカラーゼを含む蛋白質分解混合物およびその分離方法
WO1991018992A3 (en) Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen
IT1237196B (it) Peptidi sintetici e loro uso come carriers universali per la preparazione di coniugati immunogenici adatti per lo sviluppo di vaccini sintetici
RU93001102A (ru) Способ получения иммуномодулятора миелопида
HUP9902859A2 (hu) Eljárás és berendezés vörösvértest-helyettesítő készítmények előállítására
Choeh et al. Antitumor-Cytotoxic Properties of Human Tumor-Infiltrating Lymphocytes (TIL) Activated With Interleukin 2
UA10876A (uk) Комплексhа харчова добавка лікувальhо-профілактичhої дії &#34;холесорб&#34;

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-11-04